TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases TrimTech Therapeutics, a biotech company that uses targeted protein breakdown (TPD) for the treatment of neurodegenerative diseases, has today announced…